-Astrazeneca Abandons Cholesterol Drug, Cancels Deal with Abbott
M2 EquityBites › January 13, 2011
Linked as:
M2 EquityBites › January 13, 2011
Linked as:Summary
M2 EQUITYBITES-December 23, 2010--AstraZeneca abandons cholesterol drug, cancels deal with Abbott
(C)1994-2010 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
-Astrazeneca Abandons Cholesterol Drug, Cancels Deal with Abbott
23 December 2010 - Anglo-Swedish pharma major ...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Fight Forevansgoes On | match ban appeal | Short Memory? | choc tactics ; choccy sarnie 'reinvented' | newly discovered stone circle sheds light on stonehenge | governor of missouri urged to reject panel for high court | building owners managers react to terrorism alert | Women in Business: Glass Ceiling Cracked, Not Broken: Men Outnumber Women in Mba Programs